Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) biomarkers. This review
focuses on the biological characteristics of lncRNA and its value as a biomarker
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) the primary research pathways in the development of new anti-cancer medications, with a particular
focusSufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) of therapeutic biomolecules to their
target is a challenging issue, which can be solved by innovations in drug
Gilyazova, Irina,
Asadullina, Dilara,
Kagirova, Evelina,
Sikka, Ruhi,
Mustafin, Artur,
Ivanova, Elizaveta,
Bakhtiyarova, Ksenia,
Gilyazova, Gulshat,
Gupta, Saurabh,
Khusnutdinova, Elza,
Gupta, Himanshu,
Pavlov, Valentin (2023) , and tumour necrosis factor (TNF)
targeting protein receptor 6, which is a regulator of the TNF signalling
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) tools, as well as to consider them as effective
therapeutic
targets in cervical cancer.
formation and their consideration as therapeutic
targets have been well studied. In this case, accurate
Buzaev, Igor V.,
Galimova, Rezida M.,
Nabiullina, Dinara I.,
Illarioshkin, Sergey N.,
Zagidullin, Naufal Sh.,
Safin, Shamil M. (2023) )-guided
focused ultrasound (MRgFUS) treatment with an international remote online proctorship, and develop